| 1 |
27114909 | Transcriptome profiling identifies genes and pathways deregulated upon floxuridine treatment in colorectal cancer cells harboring GOF mutant p53. | 2016 Jun |
5 |
| 2 |
15207728 | The HPV16 E6/E7 oncogene sensitizes human ovarian surface epithelial cells to low-dose but not high-dose 5-FU and 5-FUdR. | 2004 Jul 16 |
2 |
| 3 |
11710597 | P53 mutation and response to hepatic arterial floxuridine in patients with colorectal liver metastases. | 2001 Nov |
1 |
| 4 |
10815759 | Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-FdCydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cells. | 2000 May |
2 |
| 5 |
9796984 | Enhanced growth inhibition and differentiation of fluorodeoxyuridine-treated human colon carcinoma cells by phenylbutyrate. | 1998 Oct |
1 |
| 6 |
9380022 | Prevention of fluorodeoxyuridine-induced cytotoxicity and DNA damage in HT29 colon carcinoma cells by conditional expression of wild-type p53 phenotype. | 1997 Oct |
1 |
| 7 |
8764107 | Fluoropyrimidine-mediated radiosensitization depends on cyclin E-dependent kinase activation. | 1996 Jul 15 |
1 |